Sherman Mark Andrew's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Dec 20, 2021
- Accession no.
- 0001209191-21-070706
- Filed
- Dec 20, 2021
- Trade date
- Dec 17-20, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $298.5K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Mark AndrewCIK 0001256708 | Officer (EVP, GEN. COUN. & SECRTY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2021 | Class A Common Stock | FTax withholdingDisposed | −1,612 | $92.00 | −$148,304 | 56,700 | Direct | |
| Dec 17, 2021 | Class A Common Stock | SSaleDisposed | −1,663 | $90.17 | −$149,952.71 | 55,037 | Direct | |
| Dec 20, 2021 | Class A Common Stock | SSaleDisposed | −1,638 | $90.69 | −$148,550.22 | 53,399 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.